CorMedix (CRMD) Misses Q4 EPS by 7c
CorMedix (NASDAQ: CRMD) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
CorMedix (NASDAQ: CRMD) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on CorMedix (CRMD) click here.